<p>The results are plotted on the log scale for each assay; the dashed lines represent the standard cutoffs for seropositivity for the assays. (A, B, C) Blue points represent enrollment serology results for those subjects who did not have an incident HPV16 infection, and red squares represent enrollment serology results for subjects for whom we detected an incident HPV16 infection. New infection was detected over four years of follow-up.</p
Individual measurements are displayed as blue and red dots for vaccinated and non-vaccinated study p...
<p>N = Number of subjects in the indicated group who received at least 1 dose of the qHPV vaccine.</...
<p>(A) Pre-pandemic seroprevalence (green), post-pandemic seroprevalence (red) and difference betwee...
<p>Out of the 639 women, who were HPV16 seropositive by ELISA at enrollment and did not develop HPV1...
A. Heat map showing the HI value for all viruses used in serological assays. Each row represents an ...
At present, seroreactivity is not a valuable parameter for diagnosis of Human Papillomavirus (HPV) i...
<p>ELISA: VLP-based direct enzyme-linked immunosorbent assay; cLIA: Competitive Luminex immunoassay;...
<p>(A) Comparison of the estimated annual rates of clearance of initial HPV-16 infection in this and...
<div><h3>Background</h3><p>Several serological assays have been developed to detect antibodies elici...
<p>SP – seropositive; SN – seronegative; QP – qPCR positive (CT cutoff 39); QN – qPCR negative; VL –...
<p>HPV titre is indicated by the height of the bar graph above the cut off with the Y axis represent...
Individual measurements are displayed as blue and red dots for vaccinated and non-vaccinated study p...
For each antigen, a seropositivity cut-off was set as the mean reactivity of malaria-naïve North Ame...
<p>Seropositivity for HPV16 and 18 by clinical setting and laboratory sending specimens</p
<p>* This study included 5,144 cervical swab samples from 548 women assigned to the placebo group of...
Individual measurements are displayed as blue and red dots for vaccinated and non-vaccinated study p...
<p>N = Number of subjects in the indicated group who received at least 1 dose of the qHPV vaccine.</...
<p>(A) Pre-pandemic seroprevalence (green), post-pandemic seroprevalence (red) and difference betwee...
<p>Out of the 639 women, who were HPV16 seropositive by ELISA at enrollment and did not develop HPV1...
A. Heat map showing the HI value for all viruses used in serological assays. Each row represents an ...
At present, seroreactivity is not a valuable parameter for diagnosis of Human Papillomavirus (HPV) i...
<p>ELISA: VLP-based direct enzyme-linked immunosorbent assay; cLIA: Competitive Luminex immunoassay;...
<p>(A) Comparison of the estimated annual rates of clearance of initial HPV-16 infection in this and...
<div><h3>Background</h3><p>Several serological assays have been developed to detect antibodies elici...
<p>SP – seropositive; SN – seronegative; QP – qPCR positive (CT cutoff 39); QN – qPCR negative; VL –...
<p>HPV titre is indicated by the height of the bar graph above the cut off with the Y axis represent...
Individual measurements are displayed as blue and red dots for vaccinated and non-vaccinated study p...
For each antigen, a seropositivity cut-off was set as the mean reactivity of malaria-naïve North Ame...
<p>Seropositivity for HPV16 and 18 by clinical setting and laboratory sending specimens</p
<p>* This study included 5,144 cervical swab samples from 548 women assigned to the placebo group of...
Individual measurements are displayed as blue and red dots for vaccinated and non-vaccinated study p...
<p>N = Number of subjects in the indicated group who received at least 1 dose of the qHPV vaccine.</...
<p>(A) Pre-pandemic seroprevalence (green), post-pandemic seroprevalence (red) and difference betwee...